Replay available

Veracyte, Inc. (VCYT) Q3 2025 Earnings Call

Veracyte, Inc. (NASDAQ: VCYT) Q3 2025 earnings conference call, held 2025-11-04. Replay captured from the company's public earnings webcast.

Tue, November 4, 2025 at 4:30 PMendedReplay
Veracyte, Inc. (VCYT) Q3 2025 Earnings Call

Hosted by

Featured presenters

Shayla Gorman

Head of Investor Relations

Mark Stathley

Chief Executive Officer

Rebecca Chambers

Chief Financial Officer

Dr. John Light

Chief Commercial Officer

Dr. Phil Fevo

Chief Medical and Scientific Officer

Doug Schenkel

Analyst, Wolfe Research

Puneet Sudha

Partner, Lyrinc Partners

Kyle Mixon

Analyst, Ken Accord

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Veracyte, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.637 Good day and thank you for standing by. Welcome to the Verisight Third Quarter 2025 Financial 00:00:05.637 -- 00:00:11.223 Results Conference Call. At this time, all participants are in a listen-only mode. 00:00:11.223 -- 00:00:14.527 After the speaker's presentation, there will be a question and answer session. 00:00:14.527 -- 00:00:19.232 To ask a question during the session, you will need to press star 1-1 on your telephone. 00:00:19.232 -- 00:00:23.596 You will then hear an automated message advising your hand is raised. 00:00:23.596 -- 00:00:26.920 To withdraw your question, please press star 1-1 again. 00:00:26.920 -- 00:00:30.507 Please be advised that today's conference is being recorded. 00:00:30.507 -- 00:00:35.893 I would now like to hand the conference over to your first speaker today, Shayla Gorman. 00:00:39.782 -- 00:00:43.629 Good afternoon, everyone, and thank you for joining us today for our discussion of our 00:00:43.629 -- 00:00:49.198 third quarter 2025 financial results. With me today are Mark Stapley, Verisight's 00:00:49.198 -- 00:00:53.980 Chief Executive Officer, and Rebecca Chambers, our Chief Financial Officer. 00:00:53.980 -- 00:00:56.604 Dr. John Light, our Chief Commercial Officer, and Dr. 00:00:56.604 -- 00:01:01.912 Phil Fevo, our Chief Medical and Scientific Officer, will join us for Q&A. 00:01:01.912 -- 00:01:06.439 Verisight issued a press release earlier this afternoon detailing our third quarter 2025 00:01:06.439 -- 00:01:11.567 financial results. This release and a copy of the presentation we will review during 00:01:11.567 -- 00:01:17.476 the call today are available in the Investors section of our website at Verisight.com. 00:01:17.476 -- 00:01:21.951 Before we begin, I'd like to remind you t...